Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.065
-0.055 (-2.59%)
Nov 6, 2025, 1:45 PM EST - Market open
Microbot Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Microbot Medical stock has a target of 12, which predicts a 481.11% increase from the current stock price of 2.07.
Price Target: $12 (+481.11%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Microbot Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +481.11% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +481.11% | Sep 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +335.84% | Apr 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +335.84% | Jan 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +238.98% | Jun 3, 2024 |
Financial Forecast
Revenue This Year
5.74M
Revenue Next Year
69.36M
from 5.74M
Increased by 1,107.73%
EPS This Year
-0.24
from -0.73
EPS Next Year
0.10
from -0.24
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 5.9M | 71.4M |
| Avg | 5.7M | 69.4M |
| Low | 5.5M | 66.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | - | 1,143.3% |
| Avg | - | 1,107.7% |
| Low | - | 1,060.4% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.25 | 0.11 |
| Avg | -0.24 | 0.10 |
| Low | -0.24 | 0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.